SAFETY AND EFFICACY OF LONG-TERM TREATMENT WITH OZANIMOD, AN ORAL S1P RECEPTOR MODULATOR, IN MODERATE TO SEVERE ULCERATIVE COLITIS: TOUCHSTONE EXTENSION 2-YEAR FOLLOW-UP

William Sandborn  1     Brian G. Feagan  2     Geert R. D'Haens  3     Steve Hanauer  4     Douglas C. Wolf  5     Severine Vermeire     Subrata Ghosh     Caiyan Li     Darryl Penenberg     AnnKatrin Petersen     Richard Aranda     Allan Olson    
1 University of California,Division of Gastroenterology,La Jolla, San Diego,United States of America
2 Robarts Research Institute, Western University,London,Canada
3 Academic Medical Center,Amsterdam,Netherlands
4 Northwestern University Feinberg School of Medicine,Chicago,United States of America
5 Atlanta Gastroentereology Associates,Atlan

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing